The Table-Integrated OR: How J&J OTTAVA's FDA Clearance Challenges Intuitive's Soft-Tissue Monopoly
Dr. Dereck Mush, MD, MBAMedTech
FDA robotic medical devices public workshop
FDA's two-day public workshop examines benefits and risks of robotic medical devices with autonomous or remote teleoperation capabilities.
- When
- December, December 2 to 3, 2026
- Where
- FDA White Oak campus and online, United StatesView on Google Maps
- Format
- Hybrid
- Organiser
- FDA Center for Devices and Radiological Health
- Region
- North America
The Signal
FDA's two-day public workshop examines benefits and risks of robotic medical devices with autonomous or remote teleoperation capabilities. The hybrid discussion brings together manufacturers, regulatory professionals, healthcare providers, patients and the public. Its discussion paper is not draft or final guidance and does not implement policy changes.
Related events
Running this event, or spotted something out of date?
Related reading
Dr. Dereck Mush, MD, MBA
The Intelligent Cath Lab: GE HealthCare, Laza Medical and the Road From AI Imaging to Robotic Intervention
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The FDA asked hard questions about AI therapy chatbots. It has not yet answered them
The FDA asked hard questions about AI therapy chatbots. It has not yet answered them
Dr. Dereck Mush, MD, MBA
How Much Weight Does Real-World Evidence Actually Carry at FDA?
Dr. Dereck Mush, MD, MBAKeep exploring